Why the study?
Because blood pressure control is crucial in chronic kidney disease, the authors investigated how office BP is influenced by measurement circumstances and compared nonautomated self- and nurse-measured BP values.
Does self-measured office blood pressure improve blood pressure assessment compared to nurse-measured office blood pressure in patients with chronic kidney disease?
Does self-measured office blood pressure improve blood pressure assessment compared to nurse-measured office blood pressure in patients with chronic kidney disease?
Self-measured and nurse-measured office blood pressure yield similar mean values in CKD patients, though individual differences of ≥10 mmHg occur in 25% of patients.
Similar BP values by self- or nurse-measurement in CKD; leaves open optimal office protocols pending larger validation.
OBJECTIVE: As blood pressure (BP) control is very important in chronic kidney disease (CKD), we investigated how office BP is influenced by the measurement circumstances and compared nonautomated self- and nurse-measured BP values. MATERIALS AND METHODS: Two hundred stage 1-5 CKD patients with scheduled visits to an outpatient clinic were randomized to either self-measured office BP (SMOBP) followed by nurse-measured office BP (NMOBP) or NMOBP followed by SMOBP. The participants had been educated to perform the self-measurement in at least one previous visit. The SMOBP and NMOBP measurement series both consisted of three recordings, and the means of the last two recordings during SMOBP and NMOBP were compared for the 174 (mean age 52.5 years) with complete BP data. RESULTS: SMOBP and NMOBP showed similar systolic (135.3 ± 16.6 vs 136.4 ± 17.4 mmHg, Δ = 1.1 mmHg, P = 0.13) and diastolic (81.5 ± 10.2 vs 82.2 ± 10.4 mmHg, Δ = 0.6 mmHg, P = 0.09) values. The change in BP from the first to the third recording was not different for SMOBP and NMOBP. In 17 patients, systolic SMOBP was ≥10 mmHg higher than NMOBP and in 28 patients systolic NMOBP exceeded SMOBP by ≥10 mmHg. The difference between systolic SMOBP and NMOBP was independent of CKD stage and the number of medications, but significantly more pronounced in patients above 60 years. CONCLUSION: In a population of CKD patients, there is no clinically relevant difference in SMOBP and NMOBP when recorded at the same visit. However, in 25% of the patients, systolic BP differs ≥10 mmHg between the two measurement modalities.
No takes yet. Share an insight, caveat, or question.
Tougaard et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: